ConductScience.org, home

Gene · 554

NIH grants1,257

NIH grants whose papers are about the gene, through NIH's grant-paper links.

181 to 200 of 1,257

Download this page as JSON
GrantTitleAVPR2 papersNewest fiscal year
U54CA2334653/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center12025
U54DK104309Investigating the Genetic, Cellular, and Metabolic Events Important for Urothelial Homeostasis and Response to Injury12025
U54DK144863Mayo Clinic Polycystic Kidney Disease Research Core Center12025
U54GM104940Louisiana Clinical and Translational Science Center12025
U54GM115428Mississippi Center for Clinical and Translational Research12025
U54MD007582FAMU Center for Health Disparities Research12025
U54MD007585Tuskegee University Center for Biomedical Research/ RCMI12025
UL1TR001860UC Davis Clinical and Translational Science Center12025
UL1TR001863Yale Clinical and Translational Science Award12025
UL1TR002369Oregon Clinical and Translational Research Institute12025
ZIAAA000550Neurobiology of Drug Reward and Addiction12025
ZIABC010329Regulation of Ras-Dependent Signal Transduction Pathways12025
ZIADA000493Functional and Pharmacological Significance of Receptor Heteromers in the CNS12025
ZIADE000561Sensory Biology12025
ZIADE000714Contribution of bone marrow cells to tissue regeneration, immune function and hematopoiesis12025
ZIADK025021Erythropoietin treatment for anemia and hematopoietic/erythroid progenitor cell responses12025
ZIADK031129Molecular basis of G protein-coupled receptor function12025
ZIAES103361cis-regulation of RNA polymerase pausing12025
ZIAHG000215Human Biochemical Genetics12025
ZIANS002263Molecular And Pharmacological Studies Of Dopamine Receptors12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/554/grants?page=10